Tom Dorozios
Chief Operating Officer

Thomas D'Orazio

Tom started his life science career at Immunex before taking on additional product management responsibilities at Pharmacia and QLT. Tom was Co-founder and CEO of Superna Life Sciences, a specialty pharmaceutical company, and served as CEO of ImmunoPrecise Antibodies where he led the company through its transition to becoming publicly traded. Tom was also most recently the COO of TRYP Therapeutics. Tom earned a BSc in chemistry from Loyola University Chicago and an MBA from Vanderbilt University.